本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ocular Therapeutix

7.00
-0.3900-5.28%
盤後6.99-0.0068-0.10%17:33 EDT
成交量:179.02萬
成交額:1,281.21萬
市值:11.15億
市盈率:-6.09
高:7.56
開:7.47
低:6.96
收:7.39
資料載入中...
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities